Royalty Pharma EVP Marshall Urist reports sale of $1.74 million in common shares
RPRX•Royalty Pharma EVP Marshall Urist sold 25,000 Class A ordinary shares on November 16, 2026, in transactions totaling about $1.74 million.
1. Share sale details
Urist sold 23,592 shares at $69.4701 and 1,408 shares at $69.9941. His remaining holdings included 125,000 shares through Sandy Lamm LLC, 19,020 through an IRA and 5,341 held directly.




